Skip to main content
Premium Trial:

Request an Annual Quote

Strand to Help Agilent 'Accelerate' GeneSpring Upgrade to Meet 'Evolving' Demand

NEW YORK (GenomeWeb News) — Strand Life Sciences will help Agilent accelerate the upgrade of its GeneSpring software in an attempt to meet “evolving customer needs,” Agilent said yesterday.
Terms of the deal call for Strand to employ its Avadis platform to “power the … GeneSpring products and enable rapid development of new functionality and analysis capabilities,” Stand CEO Vijay Chandru said in a statement.
The first version of the GeneSpring GX software developed by Strand is scheduled to be released late this year.
The deal expands on an existing relationship between Strand and Stratagene, which Agilent acquired in June. Customers of Stratagene's ArrayAssist software will be offered a “migration path” to this new version of GeneSpring.
Strand’s “expertise in delivering chemistry and biology software will accelerate our bioinformatics software development and move us toward our number-one goal of providing application and workflow solutions for customers,” Bruce von Herrmann, general manager and vice president of Agilent's Software and Informatics Division, said in the statement.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.